BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00411632 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Bexarotene
DRUG: Erlotinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]